Pharmaceutical Economics and Policy
| Year of publication: |
2006
|
|---|---|
| Authors: | Schweitzer, Stuart O. |
| Publisher: |
Oxford : Oxford University Press, USA |
| Subject: | Pharmaindustrie | Pharmaceutical industry | Arzneimittelmarkt | Pharmaceutical market | Arzneimittel | Pharmaceuticals | Gesundheitspolitik | Health policy | Theorie | Theory |
| Description of contents: | Table of Contents [external.dandelon.com] |
| Extent: | Online-Ressource (351 p.) |
|---|---|
| Type of publication: | Book / Working Paper |
| Language: | English |
| Notes: | Description based upon print version of record Cover; Contents; Introduction; The Supply of Pharmaceuticals; The Demand for Pharmaceuticals; Pharmaceutical Prices; The Multinational Pharmaceutical Industry; International Price Comparisons; Timing of Pharmaceutical Approvals; Government Intervention in the Pharmaceutical Sector; Part I. The Industry; 1 The Pharmaceutical Industry; Pharmaceutical Research and Development; The Competitive Structure of the Pharmaceutical Industry; Pharmaceutical Research and Development and Prices; The Pharmaceutical Research Process; Product Liability; Conclusions; 2 The Biotechnology Industry; Background Product Development in the Biotechnology IndustryThe Natural History of Biotechnology Firms; Case Studies of Alliances; Regulation; Case Studies of Biotechnology Firm Growth; Conclusions; 3 Other Firms in the Pharmaceutical Industry; Generic Drugs and Their Manufacturers; Outsourcing Firms; Conclusions; 4 Marketing Pharmaceuticals; Size of Marketing Effort; Does It Work?; Types of Promotion; Disguising Marketing as Research; Marketing in an Era of Managed Care; Pharmacy Benefit Managers; Direct-to-Consumer Advertising; Over-the-Counter Drugs; Joint Marketing; Disease Management Roles of the U.S. Food and Drug Administration in MarketingFalse and Misleading Claims; Part II. The Consumer; 5 The Demand for Pharmaceuticals; How Is Demand Determined?; The Changing Structure of the Pharmaceutical Market; Conclusions; Part III. The Market; 6 Pharmaceutical Prices; The Problem of Pharmaceutical Prices; Pharmaceutical Prices over Time; Measuring Drug Prices; How Are Drug Prices Determined?; Cost Structure of Pharmaceutical Firms; Is the Pharmaceutical Industry Monopolistic?; How Drug Quality Influences Price; 7 The Worldwide Market for Pharmaceuticals Geographic Patterns of Pharmaceutical Production and SalesPharmaceutical Research and Development: An International View; Does Government Drug Price Setting Influence R&D?; Worldwide Manufacturing and Sales; Access to Appropriate Drugs in Developing Countries; Effect of the World Trade Organization Treaty; 8 Pricing Pharmaceuticals in a World Environment; Why Do Drug Prices Vary Across Country?; Comparisons of International Drug Prices; How Do We Measure Drug Prices across Countries?; Why Drug Price Differences Persist; Policy Implications 9 The Timing of Drug Approvals in the United States and AbroadThe Timing of Pharmaceutical Approvals and Health Policy; The Drug Approval Process in the United States; Recent Initiatives to Expedite Drug Approvals; Is There a U.S. Drug Lag?; Part IV. Intervention in the Pharmaceutical Market: Public and Private; 10 Pharmaceutical Regulation and Cost Containment by the Public Sector; Evolution of the U.S. Food and Drug Administration; Medicaid; State Cost-Containment Efforts; Medicare; 11 Regulation by the Private Sector; Cost-Containment Mechanisms; Cost Containment in Managed Care 12 Pharmaceutical Regulation in Europe |
| ISBN: | 978-0-19-530095-6 ; 978-0-19-971974-7 ; 978-0-19-530095-6 |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10012676607